BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2008
View Archived Issues
Preclinical data on nucleoside polymerase inhibitors IDX-102, IDX-184 presented
Read More
Results from ASSIST-2 show efficacy of iclaprim in cSSSI
Read More
Met inhibitor JNJ-38877605 advanced to clinical evaluation for metastasized malignancies
Read More
SK inhibitor shows good pharmacokinetics and antitumor activity in preclinical studies
Read More
Novel Hsp90 inhibitor shows benefits in breast cancer models in vivo
Read More
Protherics reports results from phase IIb DEEP study of GSK's Digibind in preeclampsia
Read More
Agennix initiates phase II study of oral talactoferrin for severe sepsis
Read More
Amkor completes its phase I study of NEU-2000 in brain injury
Read More
FDA accepted Addrenex's NDA for CloniBID to treat hypertension
Read More
Spectrum reports positive results from phase IIb study of LHRH antagonist ozarelix in BPH
Read More
GSK to acquire Sirtris Pharmaceuticals for approximately USD 720 million
Read More
Cytheris initiates phase I clinical trial of CYT-107 in immunodeficient transplant recipients
Read More
MacroChem acquires Virium Pharmaceuticals
Read More
Alizyme reports negative results from phase III clinical trial of renzapride in IBS-C
Read More
Clinuvel announces results from its phase I studies of CUV-1647
Read More
PTC Therapeutics initiates phase IIb clinical trial of PTC-124 in DMD/BMD
Read More
European CHMP issues positive opinion for conditional approval of Tyverb
Read More
Volibris approved in E.U. for functional class II and III PAH
Read More
ACR-16 begins phase III for Huntington's disease
Read More
CHMP issues positive opinion for icatibant in HAE; FDA issues not approvable letter
Read More
CHMP issues positive opinions for two Merck medicines
Read More
Ligand initiates phase II LGD-4665 trial in idiopathic thrombocytopenic purpura
Read More
European Commission approves Viread for chronic hepatitis B
Read More
Schering-Plough/Merck receives not-approvable letter from FDA
Read More
Novel agents for treating endocrine-related disorders disclosed in recent patent literature
Read More
Data from ranibizumab AMD studies presented at the ARVO meeting
Read More
Recent Lilly and GSK patents describe new anxiolytic and antidepressant agents
Read More
Micellar formulation of calcineurin inhibitor voclosporin effective and well-tolerated in dry eye
Read More